V. Nüssler

发表

Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid

A. Schalhorn, M. Kühl, G. Stupp-Poutot, 2004, Cancer Chemotherapy and Pharmacology.

Cancer Prevention with Nutrition and Lifestyle

E. Kerschbaum, V. Nüssler, 2019, Visceral Medicine.

Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.

M. Hasmann, I. Schemainda, V. Nüssler, 2003, European journal of medical research.

131 Clinical relevance of P-glycoprotein-related resistance in patients with acute leukemia

W. Wilmanns, G. Ledderose, H. Zwierzina, 1995 .

Drug-induced apoptosis in chronic lymphocytic leukemia

W. Wilmanns, M. Scholz, V. Nüssler, 1999, Leukemia.

In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.

W. Wilmanns, H. Zwierzina, O. Stötzer, 1998, Leukemia & lymphoma.

Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.

M. Hasmann, I. Schemainda, V. Nüssler, 2006, European journal of medical research.

Involvement of ICE-Like Proteases in Gemcitabine-Induced Programmed Cell Death

W. Wilmanns, V. Heinemann, M. Zabel, 1998 .

Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding

F. Gieseler, J. Manderscheid, V. Nüssler, 2005, Annals of Hematology.

Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia.

W. Wilmanns, O. Stoetzer, V. Nüssler, 1996, Leukemia.

Topoisomerase II Activities in Human Leukemic Cells and Their Sensitivity to Anthracyclines and Podophyllotoxines

A. Glasmacher, F. Gieseler, D. Kämpfe, 1997 .

P-glycoprotein expression in patients with acute leukemia-clinical relevance.

W. Wilmanns, G. Ledderose, H. Zwierzina, 1996, Leukemia.

Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood.

R. Handgretinger, V. Gekeler, D. Niethammer, 1993, Cancer letters.

Detection of Minimal Disease in Hematological Malignancies

W. Wilmanns, H. Sauer, H. Schmetzer, 1992 .

Colonic mucosal proliferation is related to serum deoxycholic acid levels

R. Hatz, G. Paumgartner, E. Bayerdörffer, 1999, Cancer.

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

F. Gieseler, V. Nüssler, 1998, Leukemia.

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression

W. Wilmanns, H. Zwierzina, F. Gieseler, 1997, Annals of Hematology.

In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.

H. Zwierzina, P. Fenaux, D. Geissler, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

9th Immunotherapy of Cancer conference (ITOC): A meeting report

M. von Bergwelt-Baildon, S. Kobold, V. Nüssler, 2022, Human vaccines & immunotherapeutics.

4-1 BB ligand--just another costimulating molecule?

P. Kiener, H. Salih, V. Nüssler, 2002, International journal of clinical pharmacology and therapeutics.

Human P-Glycoprotein/Mdr1-Gene Product: Surprising Potential for Nuclear Localization and Coupling to Intracellular Growth Factor Signalling

W. Wilmanns, R. Radulescu, B. Zhang, 1998 .

Thymidine Kinase in Leukemic Cells: Significance for Characterization and Follow-Up of Acute Leukemia

W. Wilmanns, H. Sauer, V. Nüssler, 1993 .

Retinoblastoma protein-derived peptides: Further definition of their antineoplastic properties

W. Wilmanns, R. Radulescu, Hongyu Liu, 1997 .

Leucine zipper, nuclear targeting and P130 interaction motifs in the epidermal growth factor precursor: The nucleocrine connection further unveiled

W. Wilmanns, R. Radulescu, V. Nüssler, 1997 .

Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?

H. Salih, V. Nüssler, 2001, European journal of medical research.

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective.

M. Ellis, H. Zwierzina, B. Jönsson, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia

W. Wilmanns, H. Sauer, D. Hölzel, 1990, European journal of haematology.

Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts

Stephanie E. Combs, Thomas Kirchner, Jutta Engel, 2017, Front. Oncol..

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal

W. Wilmanns, H. Zwierzina, Bernhard Beckert, 2005, Annals of Hematology.

Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.

S. Valsamas, J. Kunze, V. Nüssler, 1998, International journal of clinical pharmacology and therapeutics.

Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.

H. Pahl, P. Stieber, V. Nüssler, 1997, Anticancer research.